Effects of p53-knockout in vascular smooth muscle cells on atherosclerosis in mice
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
In vitro and in vivo evidence has indicated that the tumor suppressor, p53, may play a significant role in the regulation of atherosclerotic plaque formation. In vivo studies using global knockout mice models, however, have generated inconclusive results that do not address the roles of p53 in various cell types involved in atherosclerosis. In this study, we have specifically ablated p53 in vascular smooth muscle cells (VSMC) in the ApoE-/- mouse model to investigate the roles of p53 in VSMC in atherosclerotic plaque formation and stability. We found that p53 deficiency in VSMC alone did not affect the overall size of atherosclerotic lesions. However, there was a significant increase in the number of p53-/- VSMC in the fibrous caps of atherosclerotic plaques in the early stages of plaque development. Loss of p53 results in migration of VSMC at a faster rate using wound healing assays and augments PDGF-induced formation of circular dorsal ruffles (CDR), known to be involved in cell migration and internalization of surface receptors. Furthermore, aortic VSMC from ApoE-/- /p53-/- mice produce significantly more podosomes and are more invasive. We conclude that p53-/- VSMC are enriched in the fibrous caps of lesions at early stages of plaque formation, which is caused in part by an increase in VSMC migration and invasion as shown by p53-/- VSMC in culture having significantly higher rates of migration and producing more CDRs and invasive podosomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Knock-out of p16 INK4a, p19 ARF, p21, and p53 had a pro-atherosclerotic effect in mice.203–205”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [205]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004) · Physiological Reviews · doi:10.1152/physrev.00041.2003 · Cited by 3,471
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
Smooth muscle cell phenotypic switching in atherosclerosis
Gomez, D., & Owens, G. K. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs115 · Cited by 866
Brozovich, F. V., Nicholson, C. J., Degen, C. V., Gao, Y. Z., Aggarwal, M., & Morgan, K. G. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.010652 · Cited by 542
Degrading Devices: Invadosomes in Proteolytic Cell Invasion
Linder, S., Wiesner, C., & Himmel, M. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154216 · Cited by 363
Newby, A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00286-7 · Cited by 362
Platelet‐derived growth factor is a chemoattractant for vascular smooth muscle cells
Grotendorst, G. R., Chang, T., Seppä, H. E. J., Kleinman, H. K., & Martin, G. R. (1982) · Journal of Cellular Physiology · doi:10.1002/jcp.1041130213 · Cited by 337
The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo
Guevara, N. V., Kim, H.-S., Antonova, E. I., & Chan, L. (1999) · Nature Medicine · doi:10.1038/6585 · Cited by 286
Feil, S., Valtcheva, N., & Feil, R. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-471-1_18 · Cited by 264
Vascular smooth muscle cell motility: From migration to invasion.
Louis, S. F., & Zahradka, P. C. (2010) · PubMed Central · Cited by 262
Williams, H., Johnson, J. L., Carson, K. G. S., & Jackson, C. L. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000014587.66321.b4 · Cited by 228
von der Thüsen, J. H., van Vlijmen, B. J. M., Hoeben, R. C., Kockx, M. M., Havekes, L. M., van Berkel, T. J. C., & Biessen, E. A. L. (2002) · Circulation · doi:10.1161/01.cir.0000015502.97828.93 · Cited by 203
Macrophage p53 Deficiency Leads to Enhanced Atherosclerosis in APOE*3-Leiden Transgenic Mice
van Vlijmen, B. J. M., Gerritsen, G., Franken, A. L., Boesten, L. S. M., Kockx, M. M., Gijbels, M. J., Vierboom, M. P., van Eck, M., van de Water, B., van Berkel, T. J. C., et al. (2001) · Circulation Research · doi:10.1161/hh0801.089261 · Cited by 171
Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent
Kinscherf, R., Claus, R., Wagner, M., Gehrke, C., Kamencic, H., Hou, D., Nauen, O., Schmiedt, W., Kovacs, G., Pill, J., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.6.461 · Cited by 134
Bennett, M. R., Littlewood, T. D., Schwartz, S. M., & Weissberg, P. L. (1997) · Circulation Research · doi:10.1161/01.res.81.4.591 · Cited by 131
Merched, A. J., Williams, E., & Chan, L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000084825.88022.53 · Cited by 126
Get Off My Back! Rapid Receptor Internalization through Circular Dorsal Ruffles
Orth, J. D., & McNiven, M. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3397 · Cited by 111
Podosome-mediated matrix resorption and cell motility in vascular smooth muscle cells
Burgstaller, G., & Gimona, M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01002.2004 · Cited by 109
Tabas, I. (2001) · Circulation Research · doi:10.1161/hh0801.090536 · Cited by 96
Webb, B. A., Eves, R. L., Crawley, S. W., Zhou, S., Côté, G. P., & Mak, A. S. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00095.2005 · Cited by 89
Self-citationCultured aortic smooth muscle cells from newborn and adult rats show distinct cytoskeletal features
Bochaton‐Piallat, M., Gabbiani, F., Ropraz, P., & Gabbiani, G. (1992) · Differentiation · doi:10.1111/j.1432-0436.1992.tb00665.x · Cited by 89
George, S. J., Angelini, G. D., Capogrossi, M. C., & Baker, A. H. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301431 · Cited by 83
The Role of p53 in Atherosclerosis
Mercer, J. R., & Bennett, M. R. (2006) · Cell Cycle · doi:10.4161/cc.5.17.3166 · Cited by 82
Mukhopadhyay, U. K., Eves, R., Jia, L., Mooney, P., & Mak, A. S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01816-08 · Cited by 76
Self-citationLi, Z., Cheng, H., Lederer, W. J., Froehlich, J. P., & Lakatta, E. G. (1997) · Experimental and Molecular Pathology · doi:10.1006/exmp.1997.2204 · Cited by 67
Waßmann, S., Wassmann, K., Jung, A., Velten, M., Knuefermann, P., Petoumenos, V., Becher, U. M., Werner, C. M., Mueller, C. F. H., & Nickenig, G. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.06.001 · Cited by 61
LRP and PDGF Signaling: A Pathway to Atherosclerosis
Boucher, P., & Gotthardt, M. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.12.001 · Cited by 59
Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion
Mukhopadhyay, U. K., Mooney, P., Jia, L., Eves, R., Raptis, L., & Mak, A. S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00004-10 · Cited by 48
Self-citationp53 gene transfer to the injured rat carotid artery decreases neointimal formation
Scheinman, M., Ascher, E., Levi, G. S., Hingorani, A., Shirazian, D., & Seth, P. K. (1999) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(99)70389-7 · Cited by 44
Mh, M., Lb, N., Shefer, S., Bm, M., & Jj, F. (1999) · PubMed · Cited by 40
Matsushita, H., Morishita, R., Aoki, M., Tomita, N., Taniyama, Y., Hironori Nakagami, A., Shimozato, T., Higaki, J., Kaneda, Y., & Ogihara, T. (2000) · Circulation · doi:10.1161/01.cir.101.12.1447 · Cited by 35
Apoptosis in atherosclerosis: pathological and pharmacological implications
Guevara, J., Chen, K.-H., & Chan, L. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0840 · Cited by 34
Poon, J. S., Eves, R. L., & Mak, A. S. (2010) · Cell Cycle · doi:10.4161/cc.9.22.13936 · Cited by 34
Self-citationYoo, S.-H., Lim, Y., Kim, S.-J., Yoo, K.-D., Yoo, H., Hong, J. T., Lee, M.-Y., & Yun, Y. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.06.003 · Cited by 33
p53 in cell invasion, podosomes, and invadopodia
Mak, A. S. (2014) · Cell Adhesion & Migration · doi:10.4161/cam.27841 · Cited by 31
Self-citationp53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells
Mak, A. S. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.2.14375 · Cited by 20
Self-citationp53: Guardian of the genome is also a suppressor of cell invasion?
Mukhopadhyay, U. K., & Mak, A. S. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9269 · Cited by 15
Self-citationPayne, L. J., Eves, R. L., Jia, L., & Mak, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108257 · Cited by 13
Self-citation
Cited by
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
Stojanović, S. D., Fiedler, J., Bauersachs, J., Thum, T., & Sedding, D. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz919 · Cited by 188
Naeini, Z., Toupchian, O., Vatannejad, A., Sotoudeh, G., Teimouri, M., Ghorbani, M., Nasli‐Esfahani, E., & Koohdani, F. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.10.012 · Cited by 71
Xi, G., Shen, X., Wai, C., White, M. F., & Clemmons, D. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005398 · Cited by 51
“Although p53 knockdown in VSMC in APOE / mice did not alter lesion size, it did increase cell number in lesions, and it enhanced invasiveness (27).”
BackgroundYang, Y., Tang, F. R., Wei, F., Yang, L., Kuang, C., Zhang, H., Deng, J., & Wu, Q. (2019) · Aging · doi:10.18632/aging.102388 · Cited by 41
“Moreover, p53 has also been highlighted as a significant regulator of atherosclerotic plaque formation [32].”
BackgroundUddin, M. A., & Barabutis, N. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102952 · Cited by 38
Metadata
- Authors
- Cao, R. Y., Eves, R., Jia, L., Funk, C. D., Jia, Z., & Mak, A. S.
- Affiliations
- Queen's University (CA)
- Corresponding author
- Mak, Alan S.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-03-31
- Volume
- 12
- Issue
- 3
- Pages
- e0175061
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5376331
- OpenAlex
- W2601395390
- Cited by
- 22
- References
- 39
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 3 · 2020: 1 · 2019: 5 · 2018: 1
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research (CA) (MOP-79468)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
- Keywords
- p53, vascular smooth muscle cells, atherosclerosis, atherosclerotic plaque stability, fibrous cap, cell migration, cell invasion, podosomes, platelet-derived growth factor, ApoE-deficient mice, tumor suppressor
- MeSH terms
- Animals, Aorta, Apolipoproteins E, Cell Movement, Cells, Cultured, Disease Models, Animal, Mice, Inbred C57BL, Microscopy, Fluorescence, Muscle, Smooth, Vascular, Tumor Suppressor Protein p53, Mice, Knockout, Myocytes, Smooth Muscle, Atherosclerosis, Mice, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.